Source: The Pharma Letter

RDD Pharma: Plans to add third pipeline to merged RDD and Innovate

The merger of Israeli gastrointestinal disorders specialist RDD Pharma and US biotech Innovate Biopharmaceuticals...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Temperato's photo - CEO of RDD Pharma

CEO

John Temperato

CEO Approval Rating

90/100

Read more